The epigenetic landscape of Alzheimer's disease

被引：0
|
作者：
Jenny Lord
Carlos Cruchaga
机构：
[1] Washington University School of Medicine,Jenny Lord and Carlos Cruchaga are in the Department of Psychiatry
[2] St. Louis,undefined
[3] Missouri,undefined
[4] USA.,undefined
[5] Carlos Cruchaga is in the Hope Center Program on Protein Aggregation and Neurodegeneration,undefined
[6] Washington University School of Medicine,undefined
[7] St. Louis,undefined
[8] Missouri,undefined
[9] USA.,undefined
来源：
Nature Neuroscience | 2014年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Two independent epigenome-wide association studies of Alzheimer's disease cohorts have identified overlapping methylation signals in four loci, ANK1, RPL13, RHBDF2 and CDH23, not previously associated with Alzheimer's disease. These studies also suggest that epigenetic changes contribute more to Alzheimer's disease than expected.
引用
收藏
页码：1138 / 1140
页数：2
相关论文
共 50 条
  • [21] The Alzheimer's disease drug development landscape
    van Bokhoven, Pieter
    de Wilde, Arno
    Vermunt, Lisa
    Leferink, Prisca S.
    Heetveld, Sasja
    Cummings, Jeffrey
    Scheltens, Philip
    Vijverberg, Everard G. B.
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [22] Evaluating the Alzheimer's disease data landscape
    Birkenbihl, Colin
    Salimi, Yasamin
    Domingo-Fernandez, Daniel
    Lovestone, Simon
    Froehlich, Holger
    Hofmann-Apitius, Martin
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2020, 6 (01)
  • [23] The Alzheimer’s disease drug development landscape
    Pieter van Bokhoven
    Arno de Wilde
    Lisa Vermunt
    Prisca S. Leferink
    Sasja Heetveld
    Jeffrey Cummings
    Philip Scheltens
    Everard G. B. Vijverberg
    Alzheimer's Research & Therapy, 13
  • [24] LANDSCAPE OF ANTIBODY IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE
    Hock, Christoph
    Grimm, Jan
    Sevigny, Jeff
    Nitsch, Roger
    Sandrock, Alfred
    NEUROBIOLOGY OF AGING, 2016, 39 : S25 - S26
  • [25] Epigenetic regulation of cognitive decline in Alzheimer's disease
    Graff, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S26 - S26
  • [26] Epigenetic drugs for Alzheimer's disease: hopes and challenges
    Caraci, Filippo
    Leggio, Gian Marco
    Drago, Filippo
    Salomone, Salvatore
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (04) : 1154 - 1155
  • [27] Epigenetic Inhibitors as Alzheimer's Disease Therapeutic Agents
    Yamashita, Yasunobu
    Itoh, Yukihiro
    Takada, Yuri
    Suzuki, Takayoshi
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2024, 72 (07) : 630 - 637
  • [28] Epigenetic modifications of DNA and RNA in Alzheimer's disease
    Martinez-Feduchi, Paula
    Jin, Peng
    Yao, Bing
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2024, 17
  • [29] Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease
    Yu, Chao-Chao
    Jiang, Tao
    Yang, Ao-Fei
    Du, Yan-Jun
    Wu, Miao
    Kong, Li-Hong
    NEURAL PLASTICITY, 2019, 2019
  • [30] An Epigenetic Manifestation of Alzheimer's Disease: DNA Methylation
    Feng, Boyi
    Zheng, Junli
    Cai, Ying
    Han, Yaguang
    Han, Yanhua
    Wu, Jiaqi
    Feng, Jun
    Zheng, Kai
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2024, 52 (03): : 365 - 374
12345